---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-23-003896"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:37:14.941436+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro Q3 net loss widens to $5.4M; cash $7.4M; clinical milestones on track

## Summary
- Net loss $5.4M ($0.06/share) vs $2.6M ($0.03/share) a year ago; R&D spend rose to $2.9M.
- Cash $7.4M at Jan 31, 2023; expects $14.8M non-dilutive note receivable in Dec 2023.
- Phase IIA topline for AL001 (Alzheimer's) expected June 2023; Phase I/IIA for ALZN002 to start March 2023.
- Working capital $5.8M; net cash used in operations $6.7M in nine months.

## SEC filing metadata
- accession: 0001214659-23-003896
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465923003896/0001214659-23-003896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465923003896/b3162308k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-23-003896
- JSON: https://secwatch.observer/filing/0001214659-23-003896.json
- Plain text: https://secwatch.observer/filing/0001214659-23-003896.txt

## Key facts
- Earnings Releases
  Alzamend Neuro, Inc. reported third quarter ended January 31, 2023 results: net income $5.4 million, or $0.06 per share.
  - Period: third quarter ended January 31, 2023
  - Net income: $5.4 million, or $0.06 per share
  - Result: reported results
  source text: Net loss for the three months ended January 31, 2023 was $5.4 million, or $0.06 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1677077/000121465923003896/0001214659-23-003896-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.